Standard BioTools Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	265.77	120.86	166.73	51.7	81.31	28.45
Short-Term Investments	189.4	66.71	126.15	63.19	84.48	18.32
Cash & Short-Term Investments	455.18	187.58	292.87	114.9	165.78	46.77
Cash Growth	76.38%	-35.95%	154.91%	-30.70%	254.46%	-31.74%
Accounts Receivable	16.64	13.43	14.74	19.66	17.28	20.83
Other Receivables	25	-	-	-	-	-
Total Trade Receivables	41.64	13.43	14.74	19.66	17.28	20.83
Inventory	18.59	19.98	20.74	20.53	21.47	20.83
Other Current Assets	6.05	233.28	47.52	3.13	4.28	4.47
Total Current Assets	521.45	454.26	375.88	158.22	208.82	72.07
Net Property, Plant & Equipment	42.65	46.01	49.34	54.85	59.54	65.15
Other Intangible Assets	-	-	-	1.4	12.6	27.93
Goodwill	-	-	-	106.32	106.25	106.38
Long-Term Investments	71.36	25.7	-	-	-	-
Other Long-Term Assets	3.66	41.78	187.12	2.29	3.11	3.69
Total Assets	639.11	567.75	612.35	323.07	390.31	275.21
Accounts Payable	8.01	5.41	5.05	9.24	7.91	10.6
Accrued Expenses	15.68	29.78	21.44	21.02	15.33	13.59
Short-Term Debt	-	-	-	-	-	6.84
Current Portion of Long-Term Debt	-	-	-	59.53	2.08	-
Current Portion of Leases	5.54	5.49	4.81	4.32	3.68	3.05
Unearned Revenue	12.97	42	13.8	15.22	14.44	15.48
Other Current Liabilities	-	25.63	20.8	-	-	-
Total Current Liabilities	42.2	108.31	65.9	109.33	43.44	49.57
Long-Term Debt	0.3	0.3	0.3	3.98	62.81	64.21
Long-Term Leases	23.65	25.04	25.59	30.37	34.08	37.55
Other Long-Term Liabilities	11.84	9.82	48.84	16.18	20.19	29.29
Total Long-Term Liabilities	35.79	35.16	74.73	50.54	117.08	131.05
Total Liabilities	77.99	143.46	140.62	159.87	160.52	180.62
Common Stock	0.41	0.4	0.4	0.08	0.08	0.08
Treasury Stock	-46.47	-46.47	-46.47	-5.98	-0.56	-
Additional Paid-in Capital	1,741	1,732	1,702	860.82	847.01	831.42
Accumulated Other Comprehensive Income	-0.51	-1.49	1.23	-2.22	-1.9	-0.91
Retained Earnings	-1,133	-1,261	-1,186	-1,001	-926.1	-736
Total Common Shareholders' Equity	561.12	424.29	471.72	-148.05	-81.47	94.6
Minority Interest	-	-	-	311.25	311.25	-
Shareholders' Equity	561.12	424.29	471.72	163.2	229.79	94.6
Total Liabilities & Equity	639.11	567.75	612.35	323.07	390.31	275.21
Total Debt	29.49	30.83	30.7	98.21	102.66	111.65
Net Cash (Debt)	425.69	156.75	262.18	16.69	63.13	-64.88
Net Cash Growth	171.57%	-40.21%	1471.35%	-73.57%	-	-
Net Cash Per Share	1.11	0.41	0.74	0.21	0.81	-0.83
Book Value	561.12	424.29	471.72	-148.05	-81.47	94.6
Book Value Per Share	1.46	1.11	1.34	-1.87	-1.04	1.21
Tangible Book Value	561.12	424.29	471.72	-255.77	-200.32	-39.71
Tangible Book Value Per Share	1.46	1.11	1.34	-3.23	-2.56	-0.51

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q